Newark, Oct. 20, 2022 (GLOBE NEWSWIRE) -- As per the report published by The Brainy Insights, the global zinc acetate market is expected to grow from USD 152.35 million in 2022 to USD 230.28 ...

Zinc Acetate Lozenges May Improve the Recovery Rate of Common Cold Patients: An Individual Patient Data Meta-Analysis. Open Forum Infectious Diseases, 2017; 4 (2) DOI: 10.1093/ofid/ofx059; ...

Eton Pharmaceuticals, Inc. announced the acquisition of Galzin® (zinc acetate), an FDA-approved medication for the maintenance treatment of Wilson Disease, an ultra-rare metabolic condition ...

There is no significant difference between zinc acetate lozenges and zinc gluconate lozenges regarding their efficacy in shortening the duration of common colds according to a meta-analysis published ...

DEER PARK, Ill., March 03, 2025 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases ...

Zinc lozenges and the common cold: a meta-analysis comparing zinc acetate and zinc gluconate, and the role of zinc dosage. JRSM Open , 2017; 8 (5): 205427041769429 DOI: 10.1177/2054270417694291 ...

DEER PARK, Ill., March 03, 2025 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc ("Eton” or the "Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing ...